1. Home
  2. INSG vs CMPX Comparison

INSG vs CMPX Comparison

Compare INSG & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inseego Corp.

INSG

Inseego Corp.

HOLD

Current Price

$14.23

Market Cap

190.1M

ML Signal

HOLD

Logo Compass Therapeutics Inc.

CMPX

Compass Therapeutics Inc.

HOLD

Current Price

$5.33

Market Cap

927.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INSG
CMPX
Founded
1996
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
190.1M
927.5M
IPO Year
2000
2020

Fundamental Metrics

Financial Performance
Metric
INSG
CMPX
Price
$14.23
$5.33
Analyst Decision
Buy
Strong Buy
Analyst Count
3
8
Target Price
$15.33
$15.83
AVG Volume (30 Days)
112.8K
2.2M
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$313,832,000.00
N/A
Revenue This Year
$16.21
N/A
Revenue Next Year
$13.28
$934.41
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.28
$1.67
52 Week High
$18.08
$6.88

Technical Indicators

Market Signals
Indicator
INSG
CMPX
Relative Strength Index (RSI) 69.71 47.54
Support Level $13.16 $4.86
Resistance Level $16.88 $5.75
Average True Range (ATR) 0.63 0.30
MACD 0.26 0.02
Stochastic Oscillator 98.06 45.21

Price Performance

Historical Comparison
INSG
CMPX

About INSG Inseego Corp.

Inseego Corp is involved in the design and development of fixed and mobile wireless solutions (4G and 5G NR), Industrial Internet of Things, and cloud solutions for enterprises, service providers, small and medium-sized businesses, governments, and consumers around the globe. Its products and services include intelligent mobile hotspots, wireless routers for IoT applications, USB modems, integrated telematics and mobile tracking devices, which are supported by application software and cloud services designed to enable customers to analyze data insights and configure and manage their hardware easily. It generates maximum revenue from the United States and Canada. The company also has a presence in Europe (including the United Kingdom).

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to target the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-A, Bispecific, and CTX-8371.

Share on Social Networks: